EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Adjuvant Therapy for Rectal Cancer

Clifford Y. Ko, Michael J. Stamos, Arthur Zimmerman, Henry C. Yang

Clinics in Colon and Rectal Surgery · 2002-01-01 · 15 (01) · 055-062

DOI: 10.1055/s-2002-23568 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT In 1990, the National Institutes of Health consensus statement for the treatment of rectal cancer concluded that ``combined postoperative chemotherapy and radiation therapy improves local control and survival in stage II and III patients and is recommended.'' Following the publication of this consensus statement, the conventional treatment for rectal cancer was bowel resection followed by adjuvant radiation and chemotherapy. In the years that followed, however, several new findings have been published and a multitude of issues has arisen. This article will attempt to succinctly focus on the best current evidence in the literature. Where possible, we include only Level I evidence (i.e., evidence from randomized controlled trials [RCTs]). Since the role of adjuvant therapy for rectal cancer is continuing to be modified, the purpose of this article is to describe and interpret the most current literature.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →